You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

71 search results for: patient burden

Importance of Lung Function Assessment in Pediatric Asthma <b>Patient</b>s
videoanimation

Importance of Lung Function Assessment in Pediatric Asthma Patients

Pulmonology
Review the burden associated with lung function decline in pediatric patients with severe asthma, and the value of clinical lung function assessments.
View more
Beyond the Signs ​and Symptoms: ​The Developmental <b>Burden</b> of AD in Children
expert video

Beyond the Signs ​and Symptoms: ​The Developmental Burden of AD in Children

Dermatology
Highlights from the ESPD 2023 ADVENT symposium: Exploring burden and comorbidities associated with moderate-to-severe atopic dermatitis in children.
View more
Impact of Type 2 Inflammation on Pediatric Atopic Dermatitis, Asthma and Eosinophilic Esophagitis
expert video

Impact of Type 2 Inflammation on Pediatric Atopic Dermatitis, Asthma and Eosinophilic Esophagitis

Type 2 Inflammation
Prof. Stephan Weidinger discusses the impact of type 2 inflammation on disease burden and clinical outcomes in pediatric patients.
View more
The Impact of Skin Fibrosis in <b>Patient</b>s with Prurigo Nodularis
videoanimation

The Impact of Skin Fibrosis in Patients with Prurigo Nodularis

Dermatology
An animated infographic exploring the patient burden and pathophysiology of skin fibrosis in prurigo nodularis, specifically detailing how fibrotic pathways are driven and the key molecules involved.
View more
Exploring Prurigo Nodularis: From Definition to Pathology and <b>Patient</b> Management
expert video

Exploring Prurigo Nodularis: From Definition to Pathology and Patient Management

Dermatology
Dr Chih-Ho Hong, Dr Sarina Elmariah, Dr Brian Kim, and Professor Sonja Ständer explored prurigo nodularis from definition to pathology and patient management.
View more
Early Intervention in Children with Atopic Dermatitis: A Window of Opportunity?
expert video

Early Intervention in Children with Atopic Dermatitis: A Window of Opportunity?

Dermatology
Highlights from the ESPD 2023 ADVENT symposium, exploring burden, skin barrier normalization, and current treatments for pediatric atopic dermatitis.
View more
ADVENT On Air | Getting to Grips With Atopic Hand and Foot Dermatitis: What Is It, and What Does It Mean for <b>Patient</b>s?
Podcast

ADVENT On Air | Getting to Grips With Atopic Hand and Foot Dermatitis: What Is It, and What Does It Mean for Patients?

Dermatology
This podcast episode looks at the epidemiology, clinical presentation and classification of atopic dermatitis of the hand and feet and the impact it has on patients' quality of life.
View more
ADVENT On Air | Defining AD in Pediatric <b>Patient</b>s
Podcast

ADVENT On Air | Defining AD in Pediatric Patients

Dermatology
Learn more about the journey of pediatric patients with AD in this conversation between Drs. Lisa Swanson and Weily Soong.
View more
Importance of Lung Function Assessment in Adult Asthma <b>Patient</b>s
videoanimation

Importance of Lung Function Assessment in Adult Asthma Patients

Pulmonology
Review the burden associated with lung function decline in adult patients with severe asthma, and the value of clinical lung function assessments.
View more
Guideline-Based Diagnosis of Atopic Dermatitis
interactivity

Guideline-Based Diagnosis of Atopic Dermatitis

Dermatology
Explore 3 interactive patient cases to learn more about the signs, symptoms, and burden of atopic dermatitis. Diagnose the patients based on a variety of cases and presentations based on American Academy of Dermatology (AAD) criteria and assess their disease severity
View more
The Evolving Understanding of Prurigo Nodularis (PN) Has Implications for <b>Patient</b> Management
Infographic

The Evolving Understanding of Prurigo Nodularis (PN) Has Implications for Patient Management

Dermatology
An infographic summarizing the clinical manifestations and pathophysiological processes of PN.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: GreeceChange country/region